| 1 |
23803225 | A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN. | 2013 Sep |
1 |
| 2 |
23136836 | Bevacizumab in combination with IFN-α in metastatic renal cell carcinoma: the AVOREN trial. | 2012 Oct |
1 |
| 3 |
18408224 | First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma. | 2008 Aug |
1 |
| 4 |
18925847 | Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma. | 2008 Oct |
2 |